Ceeable is developing a mobile augmented reality (AR) device to aid people with low vision disorders such as age related macular degeneration (AMD), diabetic retinopathy and retinitis pigmentosum. There are over 280 million people worldwide who have vision disorders and over 15 million in the united states who have AMD. The Ceeable device is based on a commercially available AR hardware platform and incorporates proprietary and patented software algorithms to map and correct for visual distortions in real time. The technology has been demonstrated to be effective in clinical studies and the results have been published in peer review journals. The company envisions the device as the first of many products that will be a significant advancement in technologies to aid low vision patients and demonstrate the capability of AR to change the human condition.